Antiviral treatment of SARS: can we draw any conclusions?
Zhaori
Getu
G
China Medical Tribune, Beijing, China.
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D012254:Ribavirin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D045169:Severe Acute Respiratory Syndrome / Q000097:blood / Q000188:drug therapy*; D013256:Steroids / Q000627:therapeutic use
D000998:Antiviral Agents; D016898:Interferon-alpha; D013256:Steroids; D012254:Ribavirin